JPH0523266B2 - - Google Patents

Info

Publication number
JPH0523266B2
JPH0523266B2 JP13195685A JP13195685A JPH0523266B2 JP H0523266 B2 JPH0523266 B2 JP H0523266B2 JP 13195685 A JP13195685 A JP 13195685A JP 13195685 A JP13195685 A JP 13195685A JP H0523266 B2 JPH0523266 B2 JP H0523266B2
Authority
JP
Japan
Prior art keywords
brown
antibiotic
culture
medium
cultured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP13195685A
Other languages
Japanese (ja)
Other versions
JPS61291585A (en
Inventor
Hamao Umezawa
Tomio Takeuchi
Masa Hamada
Hiroshi Osanawa
Hironobu Iinuma
Kazuro Shiomi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Priority to JP13195685A priority Critical patent/JPS61291585A/en
Publication of JPS61291585A publication Critical patent/JPS61291585A/en
Publication of JPH0523266B2 publication Critical patent/JPH0523266B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

〔産業上の利用分野〕 本発明は新規抗生物質MG802−AF1−Bと、
それに属する抗生物質MG802−AF1−B1、
MG802−AF1−B2及びMG802−AF1−B3の製
造法に関する。 〔従来の技術〕 微生物の生産する抗生物質は、これまでに約
5000種類報告されており、感染症の治療に広く用
いられている。このうちカイニア(Chai−nia)
属に属する微生物からは18種類の抗生物質の生産
が報告されている〔昭和59年ユサコ株式会社発
行、インデツクス オブ アクチノマイスイーテ
ス アンチバイオテイクス(In−dex of
Actinomycetes Antibiotics)〕。 〔発明が解決しようとする問題点〕 抗生物質の使用においてはその抗生物質に耐性
な菌の出現が避けられず、耐性菌に有効な新規抗
生物質は絶えず望まれている。 〔問題点を解決するための手段〕 本発明を概説すれば、本発明の第1の発明は新
規抗生物質MG802−AF1−Bに関する発明であ
つて、下記一般式: (式中、R1が水素、R2がハロゲンを表わすか、
又はR1及びR2が一緒になつて結合子を示し、R3
はハロゲンを示す)で表わされる化合物であるこ
とを特徴とする。 また本発明の第2の発明は、下記式: で表わされる化合物である抗生物質MG802−
AF1−B1、下記式: で表わされる化合物である抗生物質MG802−
AF1−B2、下記式: で表わされる化合物である抗生物質MG802−
AF1−B3の製造法に関する発明であつて、カイ
ニア属に属するMG802−AF1−B生産菌を培養
し、その培養物から抗生物質MG802−AF1−
B1、MG802−AF1−B2及びMG802−AF1−B3
よりなる群から選択した抗生物質の少なくとも1
種を分離採取することを特徴とする。 前記MG802−AF1−Bはグラム陽性菌及び多
剤耐性のグラム陽性菌に同等の抗菌活性を示すの
で、耐性菌にも有効なグラム陽性菌に対する抗生
物質として使用され得るものである。 カイニア属に属するMG802−AF1−Bの生産
菌の1例としては、本発明者らによつて昭和58年
2月新潟県佐渡群佐和田町で採取した土壌試料よ
り分離した菌株カイニア・ルブラ(Chainia
rubra)MG802−AF1(微工研菌寄第8022号)が
ある。この菌株の菌学的性状は次のとおりであ
る。 〔MG802−AF1株の菌学的性状〕 1 形態 MG802−AF1株は、顕微鏡下で分枝した基中
菌糸より、かぎ状からら旋状の気菌糸を形成し、
輪生枝は認められない。成熟した胞子鎖は10個以
上の胞子の連鎖を認め、胞子の大きさは、0.4〜
0.5×0.6〜0.7μm位である。なお、胞子の表面に
は、短かいとげ状の突起を有する。 また菌核様構造が認められ、その直径は約5〜
10μmである。 2 各種培地における生育状態 色の記載について括弧に示す標準は、コンテイ
ナー・コーポレーシヨン・オブ・アメリカ
(Container Corporation of America)のカラ
ー・ハーモニイ・マニユアル(Color harmony
manual)を用いた。 (1) シユクロース・硝酸塩寒天培地(27℃培養) うす黄だいだい〔2gc、Bamboo〕〜うす茶
〔3io、Lt Amber〕の発育上に、白〜茶白〔3ba、
Pearl〜3cb、Sand〕の気菌糸を着生し、溶解性
色素は黄茶色を帯びる程度である。 (2) グルコース・アスパラギン寒天培地(27℃培
養) 発育は無色〜うす黄だいだい〔2gc、Bam−
boo〕〜鈍だいだい〔4pe、Orange Rust〕、気菌
糸を着生せず、溶解性色素は赤茶色を帯びる程度
である。 (3) グリセリン・アスパラギン寒天培地(ISP−
培地5.27℃培養) うすだいだい〔3ic,Lt Amber〕〜うす茶
〔3le,Maple〕〜茶灰〔4lg,Lt Spice Brown〕
の発育上に、うつすらと白の気菌糸を着生し、溶
解性色素は赤茶色を帯びる程度である。 (4) スターチ・無機塩寒天培地(ISP−培地4.27
℃培養) うす黄茶〔3lg,Adobe Brown〕〜うす茶
〔4ie,Cork Tan〕〜茶灰の発育上に、白〜茶白
〔3dc,Natural〕の気菌糸を着生し、溶解性色素
は赤茶色を帯びる程度である。 (5) チロシン寒天培地(ISP−培地7.27℃培養) うす茶〜灰味赤茶〔5ng,Brick Red〕の発育
上に白〜茶白の気菌糸を着生し、赤茶の溶解性色
素を産生する。 (6) 栄養寒天培地(27℃培養) 黄茶〔3ng,Yellow Maple〕〜茶〔4ni,
Chestnut Brown〕の発育上に、培養後20日目頃
よりわずかに白の気菌糸を着生し、溶解性色素は
茶色を帯びる程度である。 (7) イースト・麦芽寒天培地(ISP−培地2,27
℃培養) 黄茶〜うす茶〔3le,Cinnamon〜3lg,Adobe
Brown〕の発育上に、白の気菌糸を着生し、溶
解性色素は赤茶色を帯びる程度である。 (8) オートミル寒天培地(ISP−培地3,27℃培
養) うすだいだい〔3gc,Lt Tan〕〜鈍だいだい
〔3ic,Lt Amber〜4ic,PastelOran−ge〕〜う
す赤味だいだい〔5ic,Lt Persi−mmon〕の発
育上に、白〜茶白〔5cb〕の気菌糸を着生し、溶
解性色素は黄茶色を帯びる程度である。 (9) グリセリン・硝酸塩寒天培地(27℃培養) 発育は、無色〜うす黄〔2gc,Bamboo〕〜う
す黄茶〔3ic,Cinnamon〕、気菌糸は着生せず、
溶解性色素は茶色味を帯びる程度である。 (10) スターチ寒天培地(27℃培養) うす黄茶〜鈍だいだい〔4ic,Pastel Oran−
ge〕の発育上に、うつすらと白の気菌糸を着生
し、溶解性色素はわずかに茶色味を呈する程度で
ある。 (11) リンゴ酸石灰寒天培地(27℃培養) 無色〜うす黄茶の発育上に、白〜茶白の気菌糸
を着生し、溶解性色素はわずかに黄色味を呈する
程度である。 (12) セルロース(紙片添加合成液、27℃培養) うす黄〜うす黄茶の発育上に、白〜茶白の気菌
糸を着生し、溶解性色素は認められない。 (13) ゼラチン穿刺培養 単純ゼラチン培地(20℃培養)、グルコース・
ペプトン・ゼラチン培地(27℃培養)共に、発育
は無色、気菌糸は着生せず、溶解性色素は認めら
れない。 (14) 脱脂牛乳(37℃培養) 発育はうす黄茶〜うす茶、気菌糸は着生せず、
溶解性色素は茶色味を帯びる程度である。 3 生理的性質 (1) 生育温度範囲 イースト・スターチ寒天培地〔可溶性デンプン
(小宗化学社製)1.0%、酵母エキス(大五栄養化
学社製)0.2%、ひも寒天3.0%、PH7.0〕を用い、
20℃、24℃、27℃、30℃、37℃、50℃の各温度で
試験の結果、50℃を除いて、そのいずれの温度で
も生育したが、最適温度は27℃〜37℃付近と推定
される。 (2) ゼラチンの液化(15%単純ゼラチン、20℃培
養:グルコース・ペプトン・ゼラチン、27℃培
養) 単純ゼラチン培地では、培養後14日目頃より液
化が始まり、その作用は弱い方である。グルコー
ス・ペプトン・ゼラチン培地では培養後30日間の
観察で、液化を認めなかつた。 (3) スターチの加水分解(スターチ。無機塩寒天
培地、及びスターチ寒天培地、いずれも27℃培
養) スターチ・無機塩寒天培地の場合は、培養後5
日目頃より、スターチ寒天培地では培養後10日目
頃より、共に水解性が認められ、その作用は中等
度である。 (4) 脱脂牛乳の凝固・ペプトン化(脱脂牛乳、37
℃培養) 培養後14日目頃より凝固が始まり、直ちに完了
後、ペプトン化が始まる。ペプトン化は培養後25
日目頃に完了する。その作用は共に中等度〜強い
方である。 (5) メラニン様色素の生成(トリプトン・イース
トプロス、ISP−培地1:ペプトン・イース
ト、鉄寒天、ISP−培地6:チロシン寒天、
ISP−培地7、いずれも27℃培養) いずれの培地でも、メラニン様色素の生成は認
められなかつた。 (6) 炭素源の利用(プリドハム・ゴドリーブ寒天
培地、ISP−培地9、27℃培養) D−グルコース、L−アラビノース、D−キシ
ロース、D−フラクトース。L−ラムノース、ラ
フイノース、D−マンニトールを利用して発育
し、イノシトールを利用しない。シユクロース
は、おそらく利用していると推定される。 (7) リンゴ酸石灰の溶解(リンゴ酸石灰寒天、27
℃培養) 培養後14日目頃から、発育周辺のリンゴ酸石灰
を溶解し、その作用は中等度である。 (8) 硝酸塩の還元反応(0.1%硝酸カリ含有ペプ
トン水、ISP−培地8、27℃培養) 陽性である。 以上の性状を要約すると、MG802−AF1株は、
胞子のうを認めず、気菌糸はかぎ状〜ら旋状を呈
し、輪生枝は認められない。胞子の表面には、短
かいとげ状の突起を有し、また、菌核様構造が認
められる。 種々の培地で、うす黄〜うす茶〜茶灰の発育上
に、白〜茶白の気菌糸を着生し、溶解性色素は、
黄〜赤茶色を帯びる。メラニン様色素の生成は陰
性、スターチの水解性は中等度である。たんぱく
分解力は、ゼラチンの液化性弱く、ミルクの凝
固・ペプトン化は、中等度〜強い方である。 MG802−AF1株の細胞壁組成は、2,6−ジ
アミノビメリン酸(diaminopimelic acid)はLL
−型、糖成分としてアラビノースを含有しない。 これらの性状より、MG802−AF1株は菌核様
構造を有するカイニア属に属する放線菌であると
推定される。更にカイニア属及びストレプトミセ
ス(Streptomyces)属より、MG802−AF1株に
類似の既知菌種を検索した結果、カイニア・ルブ
ラ(Chainia rubra)〔インターナシヨナル ジ
ヤーナル オブ システマチツク バクテリオロ
ジー(Internatinal Journal of Systematic
Bacteriology)第22巻、第347頁(1972)〕が近
縁の種として挙げられた。 第1表に文献上のカイニア・ルブラとMG802
−AF1株の比較を示す。
[Industrial Application Field] The present invention provides a novel antibiotic MG802-AF1-B,
Antibiotics belonging to it MG802-AF1-B1,
The present invention relates to a method for manufacturing MG802-AF1-B2 and MG802-AF1-B3. [Conventional technology] Until now, antibiotics produced by microorganisms have been
Over 5,000 types have been reported, and they are widely used to treat infectious diseases. Of these, Chai-nia
The production of 18 types of antibiotics has been reported from microorganisms belonging to the genus [Index of Actinomycetes Antibiotics, published by Yusako Co., Ltd.
Actinomycetes Antibiotics)]. [Problems to be Solved by the Invention] When using antibiotics, the appearance of bacteria resistant to the antibiotics is inevitable, and new antibiotics that are effective against resistant bacteria are constantly desired. [Means for Solving the Problems] To summarize the present invention, the first invention of the present invention relates to a novel antibiotic MG802-AF1-B, which has the following general formula: (In the formula, R 1 represents hydrogen, R 2 represents halogen, or
or R 1 and R 2 together indicate a conjugate, and R 3
is a halogen). Moreover, the second invention of the present invention is based on the following formula: The antibiotic MG802− is a compound represented by
AF1−B1, the following formula: The antibiotic MG802− is a compound represented by
AF1−B2, the following formula: The antibiotic MG802− is a compound represented by
This invention relates to a method for producing AF1-B3, in which an MG802-AF1-B producing bacterium belonging to the genus Cainia is cultured, and the antibiotic MG802-AF1- is produced from the culture.
B1, MG802−AF1−B2 and MG802−AF1−B3
at least one antibiotic selected from the group consisting of
It is characterized by separating and collecting seeds. Since MG802-AF1-B exhibits antibacterial activity equivalent to Gram-positive bacteria and multidrug-resistant Gram-positive bacteria, it can be used as an antibiotic against Gram-positive bacteria that is also effective against resistant bacteria. An example of a bacterial strain producing MG802-AF1-B belonging to the genus Cainia is Chainia rubra, which was isolated from a soil sample collected by the present inventors in February 1982 in Sawada-cho, Sado-gun, Niigata Prefecture.
rubra) MG802-AF1 (Feikoken Bibori No. 8022). The mycological properties of this strain are as follows. [Mycological properties of the MG802-AF1 strain] 1. Morphology The MG802-AF1 strain forms hook-shaped to spiral-shaped aerial hyphae from branched basal hyphae under a microscope.
Whorled branches are not allowed. A mature spore chain is a chain of 10 or more spores, and the size of the spores is 0.4~
It is about 0.5 x 0.6 to 0.7 μm. The surface of the spore has short thorn-like protrusions. A sclerotia-like structure was also observed, and its diameter was approximately 5 to
It is 10μm. 2. Growth status in various media The standards shown in parentheses for describing colors are the Color Harmony Manual of Container Corporation of America.
manual) was used. (1) Sucrose/nitrate agar medium (cultured at 27℃) On the growth of light yellow daisies [2gc, Bamboo] to light brown [3io, Lt Amber], white to brownish white [3ba,
Aerial mycelia of Pearl to 3cb, Sand] are grown on the plant, and the soluble pigment is only yellowish brown. (2) Glucose-asparagine agar medium (cultured at 27℃) Growth is colorless to pale yellow [2gc, Bam-
boo] ~ Dull Rust [4pe, Orange Rust], does not grow aerial mycelia, and the soluble pigment is only reddish brown. (3) Glycerin-asparagine agar medium (ISP-
Medium 5.27℃ culture) Light brown [3ic, Lt Amber] ~ Light brown [3le, Maple] ~ Tea ash [4lg, Lt Spice Brown]
On the growing surface, thin white aerial mycelium grows, and the soluble pigment is only reddish-brown. (4) Starch/inorganic salt agar medium (ISP-medium 4.27
℃ culture) Light yellow brown [3lg, Adobe Brown] ~ Light brown [4ie, Cork Tan] ~ White to brownish white [3dc, Natural] aerial mycelia are grown on the growing brown ash, and the soluble pigment is red. It has a brownish tinge. (5) Tyrosine agar medium (ISP-medium 7.27℃ culture) White to brownish aerial mycelium grows on the growth of light brown to grayish reddish brown [5ng, Brick Red] and produces reddish soluble pigment. do. (6) Nutrient agar medium (cultured at 27℃) Yellow Maple [3ng, Yellow Maple] ~ Tea [4ni,
From around 20 days after culturing, a slight white aerial mycelium grows on the growing [Chestnut Brown], and the soluble pigment is only brownish. (7) Yeast/malt agar medium (ISP-Medium 2, 27
°C culture) Yellow tea to light tea [3le, Cinnamon to 3lg, Adobe
Brown], white aerial mycelium grows on it, and the soluble pigment is only reddish-brown. (8) Oatmil agar medium (ISP-Medium 3, cultured at 27℃) Light Daidai [3gc, Lt Tan] ~ Dull Daidai [3ic, Lt Amber ~ 4ic, Pastel Oran-ge] ~ Light Red Daidai [5ic, Lt Persi- On the growth of [mmon], white to brownish white [5 cb] aerial mycelium grows, and the soluble pigment is only yellowish brown. (9) Glycerin/nitrate agar medium (cultured at 27℃) The growth is colorless to pale yellow [2gc, Bamboo] to light yellow brown [3ic, Cinnamon], with no aerial mycelia attached.
The soluble pigment has a brownish tinge. (10) Starch agar medium (cultured at 27℃) Light yellowish brown to dull yellowish brown [4ic, Pastel Oran−
ge], a thin white aerial mycelium grows on it, and the soluble pigment is only slightly brownish. (11) Malate lime agar medium (cultured at 27°C) White to brownish aerial mycelium grows on the colorless to light yellowish brown growth, and the soluble pigment is only slightly yellowish. (12) Cellulose (synthetic solution added with paper strips, cultured at 27°C) White to brownish aerial mycelium grows on the growth of light yellow to light yellowish brown, and no soluble pigments are observed. (13) Gelatin puncture culture Simple gelatin medium (cultured at 20℃), glucose/
In both peptone and gelatin media (cultured at 27°C), growth is colorless, no aerial mycelia are attached, and no soluble pigments are observed. (14) Skimmed milk (cultured at 37℃) Growth is light yellow to light brown, no aerial mycelia attached,
The soluble pigment has a brownish tinge. 3 Physiological properties (1) Growth temperature range Yeast starch agar medium [Soluble starch (manufactured by Koso Kagaku Co., Ltd.) 1.0%, yeast extract (manufactured by Daigo Nutrient Chemical Co., Ltd.) 0.2%, string agar 3.0%, PH7.0] using
As a result of tests at 20℃, 24℃, 27℃, 30℃, 37℃, and 50℃, it grew at all temperatures except 50℃, but the optimal temperature was around 27℃ to 37℃. Presumed. (2) Liquefaction of gelatin (15% simple gelatin, cultured at 20°C; glucose peptone gelatin, cultured at 27°C) In simple gelatin medium, liquefaction begins around 14 days after culture, and its effect is weak. In the glucose-peptone-gelatin medium, no liquefaction was observed during observation for 30 days after culturing. (3) Hydrolysis of starch (starch. Inorganic salt agar medium and starch agar medium, both cultured at 27°C) In the case of starch/inorganic salt agar medium, 5 days after cultivation.
On starch agar medium, water decomposition was observed from around 10 days after cultivation, and the effect was moderate. (4) Coagulation and peptonization of skimmed milk (skimmed milk, 37
(℃ culture) Coagulation begins around 14 days after culture, and immediately after completion, peptonization begins. Peptonization occurs 25 days after incubation.
It will be completed around the day. The effects are both moderate to strong. (5) Production of melanin-like pigments (tryptone yeast prosthesis, ISP-medium 1: peptone yeast, iron agar, ISP-medium 6: tyrosine agar,
(ISP-Medium 7, all cultured at 27°C) No production of melanin-like pigment was observed in any of the media. (6) Utilization of carbon sources (Pridham-Godelive agar medium, ISP-medium 9, 27°C culture) D-glucose, L-arabinose, D-xylose, D-fructose. It grows using L-rhamnose, raffinose, and D-mannitol, but does not use inositol. It is presumed that sucrose is probably used. (7) Dissolution of malate lime (malate lime agar, 27
(℃ culture) From around 14 days after culturing, malate lime around the growth is dissolved, and its effect is moderate. (8) Nitrate reduction reaction (peptone water containing 0.1% potassium nitrate, ISP-medium 8, cultured at 27°C) Positive. To summarize the above properties, the MG802-AF1 strain is
No sporangia are observed, aerial hyphae are hook-shaped to spiral-shaped, and whorled branches are not observed. The surface of the spore has short thorn-like projections and sclerotium-like structures are observed. In various media, white to brownish white aerial mycelium grows on the growth of light yellow to light brown to brown ash, and the soluble pigment is
Yellow to reddish-brown in color. The production of melanin-like pigments was negative, and the hydrolyzability of starch was moderate. Regarding protein decomposition power, gelatin has weak liquefaction ability, and milk coagulation and peptonization ability is moderate to strong. The cell wall composition of the MG802-AF1 strain is that 2,6-diaminopimelic acid is LL
- type, does not contain arabinose as a sugar component. From these properties, it is estimated that the MG802-AF1 strain is an actinomycete belonging to the genus Cainia that has a sclerotia-like structure. Furthermore, we searched for known bacterial species similar to strain MG802-AF1 from the genera Cainia and Streptomyces, and found that Chainia rubra [International Journal of Systematic Bacteriology]
Bacteriology, Vol. 22, p. 347 (1972)] was listed as a closely related species. Table 1 shows Cainia rubra and MG802 in the literature.
-Comparison of AF1 strains is shown.

【表】【table】

〔MG802−AF1−Bの製造法〕[Manufacturing method of MG802-AF1-B]

カイニア属に属するMG802−AF1−B生産菌
株を栄養源含有培地に接種して好気的に発育させ
ることによつてMG802−AF1−Bを含む培養物
が得られる。栄養源としては放線菌の栄養源とし
て使用しうるものが使用される。例えば市販され
ているペプトン、肉エキス、コーン、ステイー
ブ・リカー、綿実粉、落花生粉、大豆粉、酵母エ
キス、NZ−アミン、カゼインの水解物、硝酸ソ
ーダ、硝酸アンモニウム、硫酸アンモニウムなど
の窒素源、及び市販されているグリセリン、しよ
糖、でん粉、グルコース、ガラクトース、マンノ
ース、糖みつなどの炭水化物、あるいは脂肪など
の炭素源、及び食塩、リン酸塩、炭酸カルシウ
ム、硫酸マグネシウムなどの無機塩を使用でき
る。その他必要に応じて微量の金属塩、消泡剤と
しての動、植、鉱物油等を添加することもでき
る。これらのものは生産菌が利用し、MG802−
AF1−Bの生産に役立つものであればよく、公知
の放線菌の培養材料はすべて用いることができ
る。MG802−AF1−Bの大量生産には液体培養
が好ましく、培養温度は生産菌が発育し、
MG802−AF1−Bを生産する範囲で適用でき、
通常20〜40℃、好ましくは27〜37℃である。培養
は以上に述べた条件を使用するMG802−AF1−
B生産菌の性質に応じて適宜選択して行うことが
できる。 MG802−AF1−Bは培養液及び菌体の両方
に存在する。培養液よりは、PH10以下で酢酸ブ
チル、クロロホルム、ブタノール等水不混和性の
有機溶剤で抽出することができる。菌体よりは、
メタノール、アセトン等の有機溶剤で抽出後、抽
出液を減圧濃縮し培養液と同様の方法で更に抽
出することができる。上述の抽出法に加え、脂溶
性物質の採取に用いられる公知の方法、例えば吸
着クロマトグラフイー、ゲル過クロマトグラフ
イー、薄層クロマトグラフイーよりのかき取り、
高速液体クロマトグラフイー等を適宜組合わせあ
るいは繰返すことによつて純粋に採取することが
できる。 〔MG802−AF1−B1、MG802−AF1−B2、
MG802−AF1−B3の理化学的性状〕 MG802−AF1−B1、B2、B3の形状、質量分
析、分子式、比旋光度、紫外部吸収極大、赤外部
吸収極大、溶解性、酸性、中性、塩基性の区別、
シリカゲル薄層クロマトグラフイーのRf値を第
2表に示す。
A culture containing MG802-AF1-B can be obtained by inoculating a MG802-AF1-B producing strain belonging to the genus Cainia into a nutrient-containing medium and growing it aerobically. As the nutrient source, those that can be used as a nutrient source for actinomycetes are used. For example, commercially available nitrogen sources such as peptone, meat extract, corn, stave liquor, cottonseed flour, peanut flour, soybean flour, yeast extract, NZ-amine, casein hydrolyzate, sodium nitrate, ammonium nitrate, ammonium sulfate, and Commercially available carbohydrates such as glycerin, sucrose, starch, glucose, galactose, mannose, and molasses, or carbon sources such as fat, and inorganic salts such as common salt, phosphate, calcium carbonate, and magnesium sulfate can be used. . In addition, trace amounts of metal salts, antifoaming agents such as animal, vegetable, and mineral oils may be added as necessary. These substances are used by production bacteria, and MG802−
Any culture material for known actinobacteria can be used as long as it is useful for producing AF1-B. Liquid culture is preferred for mass production of MG802-AF1-B, and the culture temperature is set at a temperature that allows the production bacteria to grow.
Applicable within the range of producing MG802-AF1-B,
The temperature is usually 20-40°C, preferably 27-37°C. MG802−AF1− was cultured using the conditions described above.
The method can be appropriately selected depending on the properties of the B-producing bacteria. MG802-AF1-B exists in both the culture solution and the bacterial cells. The culture solution can be extracted with a water-immiscible organic solvent such as butyl acetate, chloroform, or butanol at a pH of 10 or lower. Rather than bacterial cells,
After extraction with an organic solvent such as methanol or acetone, the extract can be concentrated under reduced pressure and further extracted in the same manner as the culture solution. In addition to the above-mentioned extraction methods, known methods used to collect fat-soluble substances, such as adsorption chromatography, gel permeation chromatography, scraping from thin layer chromatography,
Pure samples can be obtained by appropriately combining or repeating high-performance liquid chromatography and the like. [MG802-AF1-B1, MG802-AF1-B2,
Physical and chemical properties of MG802-AF1-B3] Shape, mass spectrometry, molecular formula, specific rotation, ultraviolet absorption maximum, infrared absorption maximum, solubility, acidity, neutrality, base of MG802-AF1-B1, B2, B3 gender distinction,
Table 2 shows the Rf values of silica gel thin layer chromatography.

【表】 ルム−メタノー

ル40〓1で展開)
メルク社Art. 0.24
0.34
13724(メタノー
ル−水95〓5で展
開)
[Table] Lum-methanol

Expanded in Le 40〓1)
Merck Art. 0.24
0.34
13724 (developed with methanol-water 95〓5)

Claims (1)

【特許請求の範囲】 1 下記一般式: (式中、R1が水素、R2がハロゲンを表わすか、
又はR1及びR2が一緒になつて結合子を示し、R3
はハロゲンを示す)で表わされる化合物であるこ
とを特徴とする抗生物質MG802−AF1−B。 2 該一般式で表わされる化合物が、下記式
で表わされる化合物である特許請求の範囲第1項
記載の抗生物質MG802−AF1−B1。 3 該一般式で表わされる化合物が、下記式
で表わされる化合物である特許請求の範囲第1項
記載の抗生物質MG802−AF1−B2。 4 該一般式で表わされる化合物が、下記式
で表わされる化合物である特許請求の範囲第1項
記載の抗生物質MG802−AF1−B3。 5 カイニア属に属するMG802−AF1−B生産
菌を培養し、その培養物から抗生物質MG802−
AF1−B1、MG802−AF1−B2及びMG802−
AF1−B3よりなる群から選択した抗生物質の少
なくとも1種を分離採取することを特徴とする抗
生物質MG802−AF1−B1、MG802−AF1−B2、
MG802−AF1−B3の製造法。
[Claims] 1. The following general formula: (In the formula, R 1 represents hydrogen, R 2 represents halogen, or
or R 1 and R 2 together indicate a conjugate, and R 3
is a halogen). 2 The compound represented by the general formula has the following formula: The antibiotic MG802-AF1-B1 according to claim 1, which is a compound represented by: 3 The compound represented by the general formula has the following formula: The antibiotic MG802-AF1-B2 according to claim 1, which is a compound represented by: 4 The compound represented by the general formula has the following formula: The antibiotic MG802-AF1-B3 according to claim 1, which is a compound represented by: 5. Cultivate MG802-AF1-B producing bacteria belonging to the genus Cainia, and extract the antibiotic MG802-B from the culture.
AF1−B1, MG802−AF1−B2 and MG802−
Antibiotics MG802-AF1-B1, MG802-AF1-B2, characterized in that at least one antibiotic selected from the group consisting of AF1-B3 is isolated and collected;
Manufacturing method of MG802−AF1−B3.
JP13195685A 1985-06-19 1985-06-19 Novel antibiotic mg802-af1-b and production thereof Granted JPS61291585A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13195685A JPS61291585A (en) 1985-06-19 1985-06-19 Novel antibiotic mg802-af1-b and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13195685A JPS61291585A (en) 1985-06-19 1985-06-19 Novel antibiotic mg802-af1-b and production thereof

Publications (2)

Publication Number Publication Date
JPS61291585A JPS61291585A (en) 1986-12-22
JPH0523266B2 true JPH0523266B2 (en) 1993-04-02

Family

ID=15070139

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13195685A Granted JPS61291585A (en) 1985-06-19 1985-06-19 Novel antibiotic mg802-af1-b and production thereof

Country Status (1)

Country Link
JP (1) JPS61291585A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904590A (en) * 1988-12-27 1990-02-27 Eli Lilly And Company Antibiotic A80915 and process for its production

Also Published As

Publication number Publication date
JPS61291585A (en) 1986-12-22

Similar Documents

Publication Publication Date Title
US4226941A (en) Process for the optical resolution of d,l-2-amino-4-methylphosphinobutyric acid
JP2802097B2 (en) Novel anticancer antibiotic MI43-37F11 and method for producing the same
GB2031896A (en) A process for the optical resolution of D,L-2-amino-4- methylphosphinobutyric acid
EP0050724B1 (en) Process for anthracycline glycosides
JPH0523266B2 (en)
EP0050725A1 (en) Process for aclacinomycins and microorganism used therein
JP3107455B2 (en) New antibiotic MI481-42F4-A and method for producing the same
US4592999A (en) Process for producing daunomycin
EP0414914A1 (en) New substance trehalostatin and production thereof
JP2592468B2 (en) Benanomycins A and B, novel antibiotics and their production
EP0067938A1 (en) Polyprenyl sulfone derivatives, process for producing them and their uses
JPH10114777A (en) Antibiotic substance spiroximicin and its production
JPH0625095B2 (en) Antibiotic SF-2415 substance and its production method
KR810000686B1 (en) Process for the preparation of piperidine derivative
JPH0547560B2 (en)
JPH0473439B2 (en)
JP2901458B2 (en) Method for producing gentianose
JPH0283351A (en) Novel alpha-glucosidase-inhibiting substance benanomicin c and production thereof
JPH05331181A (en) Farnesyltransferase-inhibitory substance oh-4652 and its production
JPS60185797A (en) Novel anthracycline antibiotic
JPH0398591A (en) New antibiotic substance having antitumor activity and production thereof
JPH0631311B2 (en) Antibiotics RK-1061A, RK-1061B, and RK-1061C and method for producing the same
JPH0363281A (en) Novel antibiotics endynamicin and its production
JPS59162892A (en) Novel antibiotic substance rk-1339 and its preparation
JPS6121089A (en) Antibiotic 271-4sa or 271-4sb and preparation thereof